In human T-ALL, MYC is transcriptionally activated by Notch1 [55, 57], and a majority of T-ALL patients (50–60%) present with NOTCH1 gain of function mutations [23]. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.